Shareholders Equity ratio Analysis of Merrimack Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointShareholders Equity of MACK
Dec-2397.70Excellent Shareholders Equity | Dec-2297.03Excellent Shareholders Equity | Growth0.692% |
Shareholders Equity Analysis of Merrimack Pharmaceuticals Inc
| Shareholder to Equity Ratio of Merrimack Pharmaceuticals Inc with value of 97.70 indicates that shareholders own a High proportion of the assets of the company. |
| Shareholders Equity Ratio of MACK has grown by 0.692 % Compared to previous Financial Year. |
| Shareholders Equity Ratio of MACK trending up for at least three Years. |
| Shareholders Equity Ratio with value of 86.21 was lowest in Year Dec-19 in last Five Years. |
| Latest Shareholders Equity Ratio with value of 97.70 is Greater than Average Shareholders Equity of 94.51 in last five years. |
Other Shareholders Equity Related Info of MACK that may interest you.
Merrimack Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| MACK | 15.13 | 15.13 | 0 % | Biotechnology |
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation. more ..
Shareholders Equity Related Ratios
| DebtToEquityRatio | ReturnOnEquity |
Tsr Stability Index
| Excellent Stability | |
FY - Historical Shareholders Equity of Merrimack Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Shareholders Equity | 97.70 | 97.03 | 96.19 | 95.41 | 86.21 | 66.43 | 82.07 |
| Change | 0.692 % | 0.874 % | 0.817 % | 10.68 % | 29.77 % | -19.05 % | 126.63 % |
FY Chart of Shareholders Equity of Merrimack Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)